London-listed generics and API manufacturer Beximco Pharmaceuticals says it has signed a non-binding memorandum of understanding in which it may take an 85% sha 6 October 2017
Eli Lilly has announced that the Patent Trial and Appeal Board of the US Patent and Trademark Office (PTO) has ruled in the company’s favor regarding the patent 6 October 2017
Netherlands-incorporated drugmaker Mylan has received approval from the US Food and Drug Administration for its generic version of Copaxone (glatiramer acetate) 4 October 2017
The US Food and Drug Administration (FDA) has published new draft guidance for industry on making amendments to abbreviated new drug applications (ANDAs) under 4 October 2017
Scott Gottlieb, the Commissioner of the US Food and Drug Administration (FDA), has announced new policies to make it easier for the manufacturers of complex gen 3 October 2017
Netherlands-incorporated drugmaker Mylan has launched caspofungin acetate for injection, one of the first generic versions of US pharma giant Merck's & Co’s Can 3 October 2017
The US operations of New Jersey-based generics drugmaker Alvogen could be sold by its private equity owners to Shanghai Pharmaceutical Holding, according to a r 27 September 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.